3T Bioscience’s CEO Stefan Scherer MD, Ph. D, On Next Generation Oncology Research

3 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Dr. Scherer’s commitment to oncology patients took him from medical practice to research to helming 3T Biosciences, which is developing a novel T cell targeting platform.

An excerpt from "BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience" - check out the full video at https://www.bioprocessonline.com/doc/bob-jpm-stefan-scherer-m-d-ph-d-t-bioscience-0001

---
#businessofbiotech #biopharma #biotech

Subscribe to the podcast:

Apple - https://podcasts.apple.com/us/podcast/business-of-biotech/id1508008606?uo=4
Spotify - https://open.spotify.com/show/5NhjpDeHzVlXPVqT9ezKwA
YouTube - https://www.youtube.com/playlist?list=PLFXsCNKV78rWNPmqIA8b2dKYLPYYv28wb
Category
Oncology
Be the first to comment

Up Next